SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-22-014319
Filing Date
2022-11-30
Accepted
2022-11-30 16:30:18
Documents
1
Period of Report
2022-11-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-57706.html 4  
1 PRIMARY DOCUMENT marketforms-57706.xml 4 7879
  Complete submission text file 0001214659-22-014319.txt   9282
Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Issuer) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALZAMEND NEURO, INC. 3802 SPECTRUM BOULEVARD, SUITE 112C TAMPA FL 33612
Business Address
Jackman Stephan (Reporting) CIK: 0001864257 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40483 | Film No.: 221435937